(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate manufacturers
|
| | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate Basic information |
| Product Name: | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate | | Synonyms: | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3-cyano-2-methyl-4-oxo-, 1,1-dimethylethyl ester, (2S)-;tert-butyl (2S)-3-cyano-2-methyl-4-oxo-piperidine-1-carboxylate;(2S)-1-Boc-2-methyl-4-oxopiperidine-3-carbonitrile;(2S)-3-Cyano-2-methyl-4-oxopiperidine-1-carboxylicacid tert-butyl ester;tert-butyl (2S)-3-cyano-2-methyl-4-oxo-piperidine-1-carboxylate - [B85125];(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylat | | CAS: | 2212021-56-0 | | MF: | C12H18N2O3 | | MW: | 238.28 | | EINECS: | | | Product Categories: | 1 | | Mol File: | 2212021-56-0.mol |  |
| | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate Chemical Properties |
| Boiling point | 379.3±42.0 °C(Predicted) | | density | 1.13±0.1 g/cm3(Predicted) | | pka | -3.66±0.60(Predicted) | | InChI | InChI=1S/C12H18N2O3/c1-8-9(7-13)10(15)5-6-14(8)11(16)17-12(2,3)4/h8-9H,5-6H2,1-4H3/t8-,9/m0/s1 | | InChIKey | HWSFSGRTZMJYGQ-IENPIDJESA-N | | SMILES | N1(C(OC(C)(C)C)=O)CCC(=O)C(C#N)[C@@H]1C |
| | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate Usage And Synthesis |
| Uses | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate is used as an organic synthesis or pharmaceutical intermediate component. | | Hazard |
(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate causes skin irritation and serious eye irritation. It is harmful if swallowed. It may cause respiratory irritation.
|
| | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate Preparation Products And Raw materials |
|
|
Tag:(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate(2212021-56-0)
Related Product Information
|
|
(S,E)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1-(2-hydroxyvinyl)urea
\\
5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid
1H-Indole-2-carboxamide, N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-
(R)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one
3-((1S,2R)-1-(5-((R)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((R)-3- (3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1Himidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7- tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2- methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one
|